Dare Bioscience Inc (DARE) stock is lower by -12.80% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives DARE stock a score of 67 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 70. DARE's rank also includes a long-term technical score of 65. The fundamental score for DARE is 65. In addition to the average rating from Wall Street analysts, DARE stock has a mean target price of $7.20. This means analysts expect the stock to increase 560.55% over the next 12 months. DARE has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on DARE!